NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver.
D000704:Analysis of Variance; D000818:Animals; D015870:Gene Expression / Q000187:drug effects; D013006:Growth Hormone / Q000097:blood; D006146:Guanidines / Q000494:pharmacology; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood / Q000187:drug effects* / Q000235:genetics; D007334:Insulin-Like Growth Factor I / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D009566:Nitrates / Q000097:blood; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D009573:Nitrites / Q000097:blood; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017208:Rats, Wistar; D011986:Receptors, Somatotropin / Q000187:drug effects / Q000378:metabolism
D006146:Guanidines; D018972:Insulin-Like Growth Factor Binding Protein 3; D008070:Lipopolysaccharides; D009566:Nitrates; D009573:Nitrites; D012333:RNA, Messenger; D011986:Receptors, Somatotropin; D009569:Nitric Oxide; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D019001:Nitric Oxide Synthase; C004479:pimagedine